Abstract
Cardiovascular damage and diseases are associated with the leading cause of mortality worldwide. Treatments for cardiovascular damage are limited because of the lack of donors for heart transplantation. The most abundant cells in the heart, cardiomyocytes, cannot by themselves regenerate; hence cardiac tissue engineering emerges as a new treatment option for the stimulation of tissue regeneration. A key element in tissue engineering is developing tridimensional porous structures, named scaffold, that imitates the extracellular matrix of the tissue to regenerate. To promote cell adhesion, migration, differentiation, and proliferation, the scaffolds used for heart regeneration need to allow for heart mechanical contractility and electrical conductivity. Different materials commonly used for scaffold fabrication, such as collagen, silk, alginate, and chitosan, can be functionalized with nanostructures like carbon nanotubes or graphene to increase the scaffold’s electrical conductivity. Different human stem cells, such as embryonic, adipose, or bone marrow stem cells, can be cultured in the scaffold and differentiated into cardiomyocytes to obtain electroconductive tissue. Current strategies for using suitable electroconductive scaffolds in cardiac tissue engineering include developing hydrogels or cardiac patches that promote cell-electrical interactions and tissue repair.
Abbreviations
- AFM:
-
Atomic force microscopy
- AP:
-
Action potential
- APC:
-
Automatized patch-clamp
- AV:
-
Atrioventricular
- BM:
-
Bone marrow
- CDCs:
-
Centres for Disease Control
- CM:
-
Cardiomyocytes
- CNTs:
-
Carbon nanotubes
- CSCs:
-
Cardiac stem cells
- ECG:
-
Electrocardiography
- ECIS:
-
Electrical Cell substrate Impedance Spectroscopy
- ECM:
-
Extracellular matrix
- ESCs:
-
Embryonic stem cells
- FRAP:
-
Fluorescence recovering after photobleaching
- HF:
-
Heart Failure
- iPSC-CMs:
-
Induced pluripotent stem cells-derived cardiomyocytes
- iPSCs:
-
Induced pluripotent stem cells
- MMP:
-
Metalloproteinases
- MSC:
-
Mesenchymal stem cells
- NCX:
-
Na-Ca exchanger
- OSKM:
-
Oct-4, Sox2, Klf4, and c-Myc
- PANI:
-
Polyaniline
- PCL:
-
Polycaprolactone
- PEG:
-
Polyethylene glycol
- PGS:
-
Poly(glycerol sebacate)
- PLA:
-
Polylactic acid
- PLGA:
-
Poly(lactic-co-glycolic acid)
- PPY:
-
Polypyrrole
- PU:
-
Polyurethane
- RyR2:
-
Ryanodine 2 receptor (RyR2
- SA:
-
Sinoatrial
- SR:
-
Sarcoplasmic reticulum
- TATS:
-
Transverse-axial tubular system
- TIMPs:
-
Tissue inhibitors of metalloproteinases
References
Abbasgholizadeh R, Islas JF, Navran S et al (2020) A highly conductive 3D cardiac patch fabricated using cardiac myocytes reprogrammed from human adipogenic mesenchymal stem cells. Cardiovasc Eng Technol 11:205–218. https://doi.org/10.1007/s13239-019-00451-0
Abdulghani S, Mitchell G (2019) Biomaterials for in situ tissue regeneration: a review. Biomol Ther 9:750. https://doi.org/10.3390/biom9110750
Adams E, McCloy R, Jordan A et al (2021) Direct reprogramming of cardiac fibroblasts to repair the injured heart. J Cardiovasc Dev Dis 8:72. https://doi.org/10.3390/JCDD8070072
Afzal Z, Haider KH, Ashraf M (2011) Induced pluripotent stem cell derived cKitlowSca1highFlkhigh progenitor cells undergo angiomyogenic differentiation in the infarcted heart and preserve global heart function. Circulation 2011-SS-A-16946-AHA
Ahmad FB, Anderson RN (2021) The leading causes of death in the US for 2020. JAMA 325:1829. https://doi.org/10.1001/jama.2021.5469
Ahmad FB, Cisewski JA, Anderson RN (2022) Provisional mortality data – United States, 2021. MMWR Morb Mortal Wkly Rep 71:597–600. https://doi.org/10.15585/mmwr.mm7117e1
Ahmed RPH, Ashraf M, Buccini S, Shujia J, Haider KH (2011a) Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host: a note of caution. Regen Med 6:171–178
Ahmed RPH, Haider KH, Buccini S, Shujia J, Ashraf M (2011b) Reprogramming of skeletal myoblasts to induce pluripotency for tumor-free cardiomyogenesis in the infarcted heart. Circ Res 109:60–70
Alberts B, Johnson A, Lewis J (2002) Ion channels and the electrical properties of membranes. In: Molecular biology of the cell, 4th edn. Garland Science, New York
Al-Khani AM, Khalifa MA, Haider KH (2022) Mesenchymal stem cells: how close we are to their routine clinical use? In: Haider KH (ed) Handbook of stem cell therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_11-1
Al-Khani AM, Kalou Y, Haider KH (2023) Bone marrow mesenchymal stem cells for heart failure treatment: a systematic review and meta-analysis. J Heart Lung Circ 32(7):870–880
Alonzo M, AnilKumar S, Roman B et al (2019) 3D Bioprinting of cardiac tissue and cardiac stem cell therapy. Transl Res 211:64–83. https://doi.org/10.1016/j.trsl.2019.04.004
Alsharidah MS, Haider KH, Abdalla EE, Mohammed SA (2017) The skeletal muscle stem cells: biology and use in regenerative medicine. In: Haider KH (ed) Stem cells: from drug to drug discovery. Medicine & life sciences. De Gruyter, Berlin
Alvarez-Viejo M, Haider KH (2022) Mesenchymal stem cells. In: Haider KH (ed) Handbook of stem cell therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_6-1
Amin DR, Sink E, Narayan SP et al (2020) Nanomaterials for cardiac tissue engineering. Molecules 25:5189. https://doi.org/10.3390/molecules25215189
Arackal A, Alsayouri K (2022) Histology, heart. StatPearls Publishing, Treasure Island
Aziz Q, Nobles M, Tinker A (2020) Whole-cell and perforated patch-clamp recordings from acutely-isolated murine sino-atrial node cells. Bio-Protocol 10:1–9. https://doi.org/10.21769/bioprotoc.3478
Barros VN (2019) The heart cycle: a review. Women Heal 8:66–69. https://doi.org/10.15406/mojwh.2019.08.00214
Bartunek J, Behfar A, Dolatabadi D et al (2013) Cardiopoietic stem cell therapy in heart failure: the C-CURE (cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 61:2329–2338. https://doi.org/10.1016/j.jacc.2013.02.071
Belian E, Noseda M, Abreu Paiva MS et al (2015) Forward programming of cardiac stem cells by homogeneous transduction with MYOCD plus TBX5. PLoS One 10:e0125384. https://doi.org/10.1371/journal.pone.0125384
Bell DC, Fermini B (2021) Use of automated patch clamp in cardiac safety assessment: past, present and future perspectives. J Pharmacol Toxicol Methods 110:107072. https://doi.org/10.1016/j.vascn.2021.107072
Bennett DH (2013) Bennett’s cardiac arrhythmias: practical notes on interpretation and treatment, 1st edn. Wiley-Blackwell, Chichester
Bers DM (2006) Altered cardiac myocyte ca regulation in heart failure. Physiology 21:380–387. https://doi.org/10.1152/physiol.00019.2006
Bers DM (2015) Adrenergic fight-or-flight: S-NO falls on PKA targets. Circ Res 117:747–749. https://doi.org/10.1161/CIRCRESAHA.115.307397
Bers DM, Shannon TR (2013) Calcium movements inside the sarcoplasmic reticulum of cardiac myocytes. J Mol Cell Cardiol 58:59–66. https://doi.org/10.1016/j.yjmcc.2013.01.002
Bondue A, Blanpain C (2010) MESP1. A key regulator of cardiovascular lineage commitment. Circ Res 575–578. https://doi.org/10.1161/CIRCRESAHA.110.227058
Borghetti G, Von Lewinski D, Eaton DM et al (2018) Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control Front Physiol 9:1–15. https://doi.org/10.3389/fphys.2018.01514
Buccini S, Haider KH, Ahmed RPH, Jiang S, Ashraf M (2012) Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart. Basic Res Cardiol 107(6):301–314
Buckberg G, Nanda N, Nguyen C, Kocica M (2018) What is the heart? Anatomy, function, pathophysiology, and misconceptions. J Cardiovasc Dev Dis 5:33. https://doi.org/10.3390/jcdd5020033
Cagavi E, Akgul Caglar T, Soztekin GI, Haider KH (2018) Patient-specific induced pluripotent stem cells for cardiac disease modeling. In: Haider KH, Aziz S (eds) Stem cells: from hype to real hope. Medicine & life sciences. De Gruyter, Berlin
Campostrini G, Windt LM, van Meer BJ et al (2021) Cardiac tissues from stem cells. Circ Res 128:775–801. https://doi.org/10.1161/CIRCRESAHA.121.318183
Cavallini F, Tarantola M (2019) ECIS based wounding and reorganization of cardiomyocytes and fibroblasts in co-cultures. Prog Biophys Mol Biol 144:116–127. https://doi.org/10.1016/j.pbiomolbio.2018.06.010
Chandra H, Allen SW, Oberloier SW et al (2017) Open-source automated mapping four-point probe. Materials (Basel) 10:1–17. https://doi.org/10.3390/ma10020110
Chen JX, Krane M, Deutsch MA et al (2012) Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res 111:50–55. https://doi.org/10.1161/CIRCRESAHA.112.270264
Chen L, Pan Y, Zhang L et al (2013) Cellular cardiomyoplasty. Methods Mol Biol 1036:75–80. https://doi.org/10.1007/978-1-62703-511-8
Chiong M, Wang ZV, Pedrozo Z et al (2011) Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 2:e244. https://doi.org/10.1038/cddis.2011.130
Chistiakov DA, Orekhov AN, Bobryshev YV (2016) Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol 94:107–121. https://doi.org/10.1016/j.yjmcc.2016.03.015
Chorro Gascó F (2008) Electrocardiografía en la práctica clínica, 2nd edn. Publicacions de la Universitat de València, Valencia, Spain
Christoffels VM, Moorman AFM (2009) Development of the cardiac conduction system. Circ Arrhythmia Electrophysiol 2:195–207. https://doi.org/10.1161/CIRCEP.108.829341
Christoforou N, Chellappan M, Adler AF et al (2013) Transcription factors MYOCD, SRF, Mesp1, and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One 8:e63577. https://doi.org/10.1371/journal.pone.0063577
Colvin M, Smith JM, Ahn Y et al (2021) OPTN/SRTR 2019 annual data report: heart. Am J Transplant 21:356–440. https://doi.org/10.1111/ajt.16492
Coronel R, Wilders R, Verkerk AO et al (2013) Electrophysiological changes in heart failure and their implications for arrhythmogenesis. Biochim Biophys Acta Mol basis Dis 1832:2432–2441. https://doi.org/10.1016/j.bbadis.2013.04.002
D’Alessio AC, Fan ZP, Wert KJ et al (2015) A systematic approach to identifying candidate transcription factors that control cell identity. Stem Cell Reports 5:763–775. https://doi.org/10.1016/j.stemcr.2015.09.016
Danielson L, Park D, Rotllan N, Chamorro-Jorganes A et al (2013) Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J 27:1460–1467. https://doi.org/10.1096/fj.12-221994
Du C, Feng Y, Qiu D et al (2018) Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails. Stem Cell Res Ther 9:58. https://doi.org/10.1186/s13287-018-0794-4
Ebert AD, Diecke S, Chen IY, Wu JC (2015) Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? EMBO Mol Med 7:1090–1103. https://doi.org/10.15252/emmm.201504395
Fabry B, Maksym GN, Butler JP et al (2001) Scaling the microrheology of living cells. Phys Rev Lett 87:1–4. https://doi.org/10.1103/PhysRevLett.87.148102
Fakoya AOJ, Omole AE, Satyadev N, Haider HK (2022) Induced pluripotent stem cells: progress towards clinical translation from bench to bedside. In: Haider KH (ed) Handbook of stem cell therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_31-1
Feng B, Jiang J, Kraus P et al (2009) Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 11:197–203. https://doi.org/10.1038/ncb1827
Gaj T, Gersbach CA, Barbas CF (2013) ZFN, TALEN and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31:397. https://doi.org/10.1016/J.TIBTECH.2013.04.004
Gam R, Sung M, Pandurangan AP (2019) Experimental and computational approaches to direct cell reprogramming: recent advancement and future challenges. Cell 8:1189. https://doi.org/10.3390/cells8101189
Garry GA, Bassel-Duby R, Olson EN (2022) Direct reprogramming as a route to cardiac repair. Semin Cell Dev Biol 122:3–13. https://doi.org/10.1016/j.semcdb.2021.05.019
Goldman L (2020) Principles of electrophysiology. In: Goldman-Cecil medicine, 24th edn. Elsevier Health Sciences, London
Gonzalez-Villarreal CA, Quiroz-Reyes AG, Islas JF, Garza-Treviño EN (2020) Colorectal cancer stem cells in the progression to liver metastasis. Front Oncol 10:1–17. https://doi.org/10.3389/fonc.2020.01511
Graf T, Enver T (2009) Forcing cells to change lineages. Nature 462:587–594. https://doi.org/10.1038/nature08533
Grath A, Dai G (2019) Direct cell reprogramming for tissue engineering and regenerative medicine. J Biol Eng 13:1–15. https://doi.org/10.1186/s13036-019-0144-9
Guo B, Ma PX (2018) Conducting polymers for tissue engineering. Biomacromolecules 19:1764–1782. https://doi.org/10.1021/acs.biomac.8b00276
Guo C, Zhu K, Haider KH (2017a) Nanoparticle-based genetic engineering of mesenchymal stem cells. In: Haider KH (ed) Stem cells: from drug to drug discovery. Medicine & life sciences. De Gruyter, Berlin
Guo R, Tang W, Yuan Q et al (2017b) Chemical cocktails enable hepatic reprogramming of mouse fibroblasts with a single transcription factor. Stem Cell Reports 9:499–512. https://doi.org/10.1016/j.stemcr.2017.06.013
Guo X, Xu Y, Wang Z et al (2018) A Linc1405/Eomes complex promotes cardiac mesoderm specification and cardiogenesis. Cell Stem Cell 22:893–908.e6. https://doi.org/10.1016/j.stem.2018.04.013
Haider KH, Ashraf M (2005) Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol 38:225–235
Haider KH, Khan M, Sen C (2015) MicroRNAs with mega functions in cardiac remodeling andrepair: the micro management of the matters of the heart. In MicroRNA in Regenerative Medicine pp: 596–600
Hall JE, Hall ME (2020) Guyton and hall textbook of medical physiology, 14th edn. Elsevier, Philadelphia
Hogan M, Mohamed M, Tao ZW et al (2015) Establishing the framework to support bioartificial heart fabrication using fibrin-based three-dimensional artificial heart muscle. Artif Organs 39:165–171. https://doi.org/10.1111/aor.12318
Huang CF, Chen YC, Yeh HI, Chen SA (2012) Mononucleated and binucleated cardiomyocytes in the left atrium and pulmonary vein have different electrical activity and calcium dynamics. Prog Biophys Mol Biol 108:64–73. https://doi.org/10.1016/j.pbiomolbio.2011.09.007
Ibrahim AY, Mehdi Q, Abbas AO, Alashkar A, Haider KH (2016) Induced pluripotent stem cells: next-generation cells for tissue regeneration. J Biomed Sci Eng 9(4):226–244
Ichida JK, Blanchard J, Lam K et al (2009) A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 5:491–503. https://doi.org/10.1016/j.stem.2009.09.012
Islas JF, Liu Y, Weng K-C et al (2012) Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc Natl Acad Sci 109:13016–13021. https://doi.org/10.1073/pnas.1120299109
Janse M (2004) Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 61:208–217. https://doi.org/10.1016/j.cardiores.2003.11.018
Janssens S, Dubois C, Bogaert J et al (2006) Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized controlled trial. Lancet 367:113–121. https://doi.org/10.1016/S0140-6736(05)67861-0
Joukar S (2021) A comparative review on heart ion channels, action potentials, and electrocardiogram in rodents and human: extrapolation of experimental insights to the clinic. Lab Anim Res 37:1–15. https://doi.org/10.1186/s42826-021-00102-3
Kamal M, Kassem D, Haider KH (2022) Sources and therapeutic strategies of mesenchymal stem cells in regenerative medicine. In: Haider KH (ed) Handbook of stem cell therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_2-1
Karakikes I, Senyei GD, Hansen J et al (2014) Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem Cells 3:18–31
Karp G, Iwasa J, Marshall W (2019) Karp’s cell & molecular biology. Wiley, Hoboken
Kattman SJ, Witty AD, Gagliardi M et al (2011) Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8:228–240. https://doi.org/10.1016/j.stem.2010.12.008
Krieg M, Fläschner G, Alsteens D et al (2018) Atomic force microscopy-based mechanobiology. Nat Rev Phys 1:41–57. https://doi.org/10.1038/s42254-018-0001-7
Kwon D-H, Eom GH, Kee HJ et al (2013) Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4. J Mol Cell Cardiol 65:88–97. https://doi.org/10.1016/j.yjmcc.2013.09.011
Lachaize V, Formosa-Dague C, Smolyakov G et al (2015) Atomic force microscopy: an innovative technology to explore cardiomyocyte cell surface in cardiac physio/pathophysiology. Lett Appl NanoBioScience 4:321–324
Lázár E, Sadek HA, Bergmann O (2017) Cardiomyocyte renewal in the human heart: insights from the fall-out. Eur Heart J 38:2333–2342. https://doi.org/10.1093/eurheartj/ehx343
Liu Y, Chen L, Diaz AD et al (2016) Mesp1 marked cardiac progenitor cells repair infarcted mouse hearts. Sci Rep 6:1–14. https://doi.org/10.1038/srep31457
Macaya Miguel C, López Farré A (2009) Fisiologia Cardiaca. In: Libro de la salud cardiovascular del Hospital Clínico San Carlos y la Fundación BBVA. Fundación BBVA, Bilbao, pp 41–47
Madonna R, Van Laake LW, Botker HE et al (2019) ESC working group on cellular biology of the heart: position paper for cardiovascular research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure. Cardiovasc Res 115:488–500. https://doi.org/10.1093/cvr/cvz010
Mahadevan V (2018) Anatomy of the vertebral column. Surgery. 7:43–47
Majid QA, Fricker ATR, Gregory DA et al (2020) Natural biomaterials for cardiac tissue engineering: a highly biocompatible solution. Front Cardiovasc Med 7:1–32. https://doi.org/10.3389/fcvm.2020.554597
Maráková N, Boeva ZA, Humpolíček P et al (2019) Electrochemically prepared composites of graphene oxide and conducting polymers: cytocompatibility of cardiomyocytes and neural progenitors. Mater Sci Eng C 105:110029. https://doi.org/10.1016/j.msec.2019.110029
Marotta P, Cianflone E, Aquila I et al (2018) Combining cell and gene therapy to advance cardiac regeneration. Expert Opin Biol Ther 18:409–423. https://doi.org/10.1080/14712598.2018.1430762
Marson A, Foreman R, Chevalier B et al (2008) Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3:132–135. https://doi.org/10.1016/j.stem.2008.06.019
Mohamed MA, Islas JF, Schwartz RJR, Birla RK (2017) Electrical stimulation of artificial heart muscle: a look into the electrophysiologic and genetic implications. ASAIO J 63:333–341. https://doi.org/10.1097/MAT.0000000000000486
Mummery CL, Zhang J, Ng E et al (2012) Differentiation of human ES and iPS cells to cardiomyocytes: a methods overview. Circ Res 111:344–358. https://doi.org/10.1161/CIRCRESAHA.110.227512.Differentiation
Nass RD, Aiba T, Tomaselli GF, Akar FG (2008) Mechanisms of disease: ion channel remodeling in the failing ventricle. Nat Clin Pract Cardiovasc Med 5:196–207. https://doi.org/10.1038/ncpcardio1130
Nattel S, Maguy A, Le Bouter S, Yeh Y-H (2007) Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87:425–456. https://doi.org/10.1152/physrev.00014.2006
Neher E, Sakmann B (1976) Noise analysis of drug-induced voltage clamp currents in denervated frog muscle fibers. J Physiol 258:705–729. https://doi.org/10.1113/jphysiol.1976.sp011442
Nielsen MS, Nygaard Axelsen L, Sorgen PL et al (2012) Gap junctions. Comprehensive physiology 3:1981–2035. https://doi.org/10.1002/cphy.c110051
Noggle S, Fung H-L, Gore A et al (2011) Human oocytes reprogram somatic cells to a pluripotent state. Nature 478:70–75. https://doi.org/10.1038/nature10397
Omole AE, Fakoya AOJ, Nnawuba KC, Haider KH (2022) Common ethical considerations of human induced pluripotent stem cell research. In: Haider KH (ed) Handbook of stem cell therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_40-1
Padala SK, Cabrera J, Ellenbogen KA (2021) Anatomy of the cardiac conduction system. Pacing Clin Electrophysiol 44:15–25. https://doi.org/10.1111/pace.14107
Parchehbaf-Kashani M, Sepantafar M, Talkhabi M et al (2020) Design and characterization of an electroconductive scaffold for cardiomyocytes based biomedical assays. Mater Sci Eng C 109:110603. https://doi.org/10.1016/j.msec.2019.110603
Pasha Z, Haider KH, Ashraf M (2011a) Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule for generating cardiac progenitor cells. PLoS One 6(8):e23667
Pasha Z, Haider K, Ashraf M (2011b) Non viral reprogramming of skeletal myoblasts to stemness by single small molecule: miR profiling and cardiac regeneration. Circulation Nov. 2011-SS-A-13941-AHA
Prieto González EA, Haider KH (2021) Genomic instability in stem cells: the basic issues. In: Haider KH (ed) Stem cells: from potential to promise. Springer, Singapore. https://doi.org/10.1007/978-981-16-0301-3_5
Protze S, Khattak S, Poulet C et al (2012) A new approach to transcription factor screening for reprogramming fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol 53:323–332. https://doi.org/10.1016/j.yjmcc.2012.04.010
Puthagram RPH, Buccini S, Jiang S, Haider KH (2012) Surrogate progenitors for cardiogenesis: direct reprogramming of somatic cells to cross lineage restriction without pluripotency. Circulation
Raghunathan S, Islas JF, Mistretta B et al (2020) Conversion of human cardiac progenitor cells into cardiac pacemaker-like cells. J Mol Cell Cardiol 138:12–22. https://doi.org/10.1016/j.yjmcc.2019.09.015
Rikhtegar R, Pezeshkian M, Dolati S et al (2019) Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts. Biomed Pharmacother 109:304–313. https://doi.org/10.1016/j.biopha.2018.10.065
Roacho-Pérez JA, Garza-Treviño EN, Moncada-Saucedo NK et al (2022) Artificial scaffolds in cardiac tissue engineering. Life 12:1117. https://doi.org/10.3390/life12081117
Roddy M, Tsonis PA (2008) The newt as a model for eye regeneration. In: Tsonis PA (ed) Animal models in eye research. Elsevier, San Diego, pp 93–101
Ross MH, Wojciech P (2010) Histology: a text and atlas, with correlated cell and molecular biology, 6th edn. Lippincott Williams & Wilkins, Baltimore
Rother J, Richter C, Turco L et al (2015) Crosstalk of cardiomyocytes and fibroblasts in co-cultures. Open Biol 5:150038. https://doi.org/10.1098/rsob.150038
Sadahiro T, Yamanaka S, Ieda M (2015) Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. Circ Res 116:1378–1391. https://doi.org/10.1161/CIRCRESAHA.116.305374
Sakamoto T, Matsuura TR, Wan S et al (2020) A critical role for estrogen-related receptor signaling in cardiac maturation. Circ Res 126:1685–1702. https://doi.org/10.1161/CIRCRESAHA.119.316100
Santiago JJ, Dangerfield AL, Rattan SG et al (2010) Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 239:1573–1584. https://doi.org/10.1002/dvdy.22280
Sattar Y, Chhabra L (2022) Electrocardiogram. StatPearls Publishing, Treasure Island
Scardigli M, Crocini C, Ferrantini C et al (2017) Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy. Proc Natl Acad Sci U S A 114:5737–5742. https://doi.org/10.1073/pnas.1702188114
Schachinger V, Erbs S, Elsasser A et al (2006) Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27:2775–2783. https://doi.org/10.1093/eurheartj/ehl388
Schächinger V, Erbs S, Elsässer A et al (2006) Intracoronary bone marrow–derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210–1221. https://doi.org/10.1056/NEJMoa060186
Schäffler A, Büchler C (2007) Concise review: adipose tissue-derived stromal cells – basic and clinical implications for novel cell-based therapies. Stem Cells 25:818–827. https://doi.org/10.1634/stemcells.2006-0589
Seibertz F, Rapedius M, Fakuade FE et al (2022) A modern automated patch-clamp approach for high throughput electrophysiology recordings in native cardiomyocytes. Commun Biol 5:969. https://doi.org/10.1038/s42003-022-03871-2
Sekiya S, Suzuki A (2011) Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 475:390–393. https://doi.org/10.1038/nature10263
Shen D, Cheng K, Marbán E (2012) Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J Cell Mol Med 16:2112–2116. https://doi.org/10.1111/j.1582-4934.2011.01512.x
Shi Y, Desponts C, Do JT et al (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3:568–574. https://doi.org/10.1016/j.stem.2008.10.004
Spadaccio C, Rainer A, Mozetic P et al (2015) The role of extracellular matrix in age-related conduction disorders: a forgotten player? J Geriatr Cardiol 12:76–82. https://doi.org/10.11909/j.issn.1671-5411.2015.01.009
Stein M, Noorman M, van Veen TAB et al (2008) Dominant arrhythmia vulnerability of the right ventricle in senescent mice. Hear Rhythm 5:438–448. https://doi.org/10.1016/j.hrthm.2007.10.033
Subramanyam D, Lamouille S, Judson RL et al (2011) Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 29:443–448. https://doi.org/10.1038/nbt.1862
Tadevosyan K, Iglesias-García O, Mazo MM et al (2021) Engineering and assessing cardiac tissue complexity. Int J Mol Sci 22:1479. https://doi.org/10.3390/ijms22031479
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676. https://doi.org/10.1016/j.cell.2006.07.024
Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872. https://doi.org/10.1016/j.cell.2007.11.019
Takamiya M, Haider KH, Ashraf M (2011) Identification and characterization of a novel multipotent sub-population of sca-1+ cardiac progenitor cells for myocardial regeneration. PLoS One 6(9):e25265
Tzahor E, Poss KD (2017) Cardiac regeneration strategies: staying young at heart. Science 80(356):1035–1039. https://doi.org/10.1126/science.aam5894
Uçkan-Çetinkaya D, Haider KH (2021) Chapter 13: Induced pluripotent stem cells in pediatric research and clinical translation. In: Haider KH (ed) Stem cells. Springer, Cham, pp 203–214. https://doi.org/10.1007/978-3-030-77052-5_13
van Weerd JH, Christoffels VM (2016) The formation and function of the cardiac conduction system. Development 143:197–210. https://doi.org/10.1242/dev.124883
Wang Y, Liu YZ, Wang SY, Wang Z (2016) In vivo whole-cell recording with high success rate in anaesthetized and awake mammalian brains. Mol Brain 9:1–14. https://doi.org/10.1186/s13041-016-0266-7
Wang X, Wang L, Dou W et al (2020) Electrical impedance-based contractile stress measurement of human iPSC-cardiomyocytes. Biosens Bioelectron 166:112399. https://doi.org/10.1016/j.bios.2020.112399
Wang Z, Wang L, Li T et al (2021) 3D bioprinting in cardiac tissue engineering. Theranostics 11:7948–7969. https://doi.org/10.7150/thno.61621
Wei X, Yohannan SRJ (2022) Physiology, cardiac repolarization dispersion and reserve. StatPearls Publishing, Treasure Island
Wiegerinck RF, van Veen TAB, Belterman CN et al (2008) Transmural dispersion of refractoriness and conduction velocity is associated with heterogeneously reduced connexin43 in a rabbit model of heart failure. Hear Rhythm 5:1178–1185. https://doi.org/10.1016/j.hrthm.2008.04.026
Woods NB, Ooka A, Karlsson S (2002) Development of gene therapy for hematopoietic stem cells using lentiviral vectors. Leukemia 16:563
Wright G, Sibarita J-B (2016) Fluorescence recovery after photobleaching (FRAP). In: Practical manual for fluorescence microscopy techniques pp 3–11
Xie A, Zhou A, Liu H et al (2018) Mitochondrial Ca2+ flux modulates spontaneous electrical activity in ventricular cardiomyocytes. PLoS One 13:1–17. https://doi.org/10.1371/journal.pone.0200448
Xie D, Xiong K, Su X et al (2021) Identification of an endogenous glutamatergic transmitter system controlling excitability and conductivity of atrial cardiomyocytes. Cell Res 31:951–964. https://doi.org/10.1038/s41422-021-00499-5
Xin M, Olson EN, Bassel-duby R (2013) Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol 14:529–541. https://doi.org/10.1038/nrm3619.Mending
Xing H, Lee H, Luo L, Kyriakides TR (2020) Extracellular matrix-derived biomaterials in engineering cell function. Biotechnol Adv 42:107421. https://doi.org/10.1016/j.biotechadv.2019.107421
Yang L, Soonpaa MH, Adler ED et al (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453:524–528. https://doi.org/10.1038/nature06894
Yilmaz HD, Arslan YE (2023) Chapter 14: Avant-Garde hydrogels as stem cell niche for cardiovascular regenerative medicine. In: Haider KH (ed) Stem cells: cardiovascular applications. Springer, Singapore
Yoder KE, Rabe AJ, Fishel R, Larue RC (2021) Strategies for targeting retroviral integration for safer gene therapy: advances and challenges. Front Mol Biosci 8:662331. https://doi.org/10.3389/fmolb.2021.662331
Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 80(318):1917–1920. https://doi.org/10.1126/science.1151526
Zaruba M-M, Soonpaa M, Reuter S, Field LJ (2010) Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation 121:1992–2000. https://doi.org/10.1161/CIRCULATIONAHA.109.909093
Zhang GQ, Zhang W (2009) Heart rate, lifespan, and mortality risk. Ageing Res Rev 8:52–60. https://doi.org/10.1016/j.arr.2008.10.001
Zhu S, Li W, Zhou H et al (2010) Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7:651–655. https://doi.org/10.1016/j.stem.2010.11.015
Zipes DP, Jalife JSW (2018) Cardiac electrophysiology from cell to bedside, 7th edn. Elsevier, Philadelphia
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Roacho-Perez, J.A., Santoyo-Suarez, M.G., Quiroz-Reyes, A.G., Garza-Treviño, E.N., Islas, J.F., Haider, K.H. (2023). Current Developments of Electroconductive Scaffolds for Cardiac Tissue Engineering. In: Haider, K.H. (eds) Handbook of Stem Cell Applications. Springer, Singapore. https://doi.org/10.1007/978-981-99-0846-2_55-1
Download citation
DOI: https://doi.org/10.1007/978-981-99-0846-2_55-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-0846-2
Online ISBN: 978-981-99-0846-2
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences